CRA was retained by a Fortune 100 pharmaceutical company to assess the multi-year selection process associated with a recent acquisition. Working with the client CRA developed analyses to examine the impact decisions commonly associated with blending companies. The analyses incorporated different selection processes for areas of overlap, merger required spin-offs, as well as general workforce adjustments. CRA’s analyses provided a “real-time” review of the decisions as they were being made to address particular areas of risk.
The impacts of same and opposite gender alumni speakers on interest in economics
For the journal Economics of Education Review, CRA’s Arpita Patnaik with her coauthors Gwyn Pauley, Joanna Venator and Matthew Wiswall have written the paper...